Pipeline

Medium without sidebar

PETER NICKLIN APPOINTED EXECUTIVE CHAIRMAN

 Former President EMEA of Baxter International, Peter Nicklin, Appointed Executive Chairman Vevey, May 23, 2016 — The Board of Directors of Vaxeal Group today announced the appointment of Mr Peter Nicklin as Executive Chairman of the Company, effective on June 1st, 2016. Peter Nicklin has been a Director of Vaxeal since January 1st, 2016. He […]
  • Posted by Elliot Willcox
  • On 26 May 2016
  • 0 Comments
  • Read More

AHMED BOUZIDI, PANELIST AT THE 4th ANNUAL EAPM PRESIDENCY CONFERENCE

Ahmed Bouzidi, panelist at the 4th Annual Presidency Conference “Taking Stock: Where we are now and the necessary next steps” Brussels, April 6th, 2016: Ahmed Bouzidi was panelist at the Plenary Session III: « Value of Innovation, Access and Incentives ». Other panelists were: Tom Fowler, Director Public Health for Genomics England – Giovanni Martinelli, University of […]
  • Posted by Elliot Willcox
  • On 16 April 2016
  • 0 Comments
  • Read More

VAXEAL PARTICIPATED IN THE IPROVE ROADMAP

Vaxeal participated in the IProve Roadmap to foster vaccine innovation launched in European Parliament IPROVE roadmap informs strategic decisions on the priorities for future vaccine investment Brussels, 16 March 2016: The “Innovation Partnership for a Roadmap on Vaccines in Europe” (IPROVE) – financed under the EU 7th Framework Programme (FP7) – today launched a strategy […]
  • Posted by Elliot Willcox
  • On 28 March 2016
  • 0 Comments
  • Read More

ANR CONSORTIUM SUBMITS 1st INTERMEDIATE REPORT ON SVX-1

THE MEMBERS OF THE ANR-13-RPIB-0004 CONSORTIUM SUBMITTED THE FIRST INTERMEDIATE REPORT ON SVX-1 1st June 2015 Evry, 01 June, 2015 – The consortium involving VAXEAL RESEARCH SAS, INSERM, The UNIVERSITY PARIS DESCARTES (PARIS 5), AP-HP, and the CEA, today announced that they have successfully reached the first milestone related to the pre-clinical development of SVX-1 Therapeutic Vaccine, […]
  • Posted by Elliot Willcox
  • On 12 December 2015
  • 0 Comments
  • Read More

FORMER PRESIDENT EMEA OF BAXTER INTERNATIONAL, PETER NICKLIN, JOINS VAXEAL BOARD OF DIRECTORS

Vevey, December 11, 2015 — The Board of Directors of Vaxeal Group today announced the appointment of Mr Peter Nicklin as an independent director of the Company, effective immediately. Mr Nicklin’s appointment expands the Board to 7 directors, 4 of whom are independent directors.Peter Nicklin has spent 25 years in the healthcare industry. He has […]
  • Posted by Elliot Willcox
  • On 11 December 2015
  • 0 Comments
  • Read More

AHMED BOUZIDI PRESENTED AT THE iPROVE WORKSHOP

Ahmed Bouzidi, presented at the iProve workshop for therapeutic vaccines and SMEs organized by Vaccines Europe Brussels, 26 May 2015 – Vaxeal Holding today announced that Dr Ahmed Bouzidi, CEO of the company, made a presentation on “EUROPEAN THERAPEUTIC VACCINE SMEs, EUROPEAN ECOSYSTEM AND CHALLENGES” at the IPROVE Workshop on Therapeutic Vaccines organized by Vaccines […]
  • Posted by Elliot Willcox
  • On 26 May 2015
  • 0 Comments
  • Read More

AHMED BOUZIDI PRESENTED AT THE STAKEHOLDER VAX 1-2-1

Vevey, 20 May 2015 – Vaxeal Holding today announced that Dr. Ahmed Bouzidi, CEO of the company, made an oral presentation entitled “Case Study: Survivin cancer vaccine pre-clinical PoC” at the VAX 1-2-1 in Amsterdam. Ahmed Bouzidi also was the chairman of the session “Therapeutic Vaccines: Looking Beyond Infectious Diseases”.For further information, please visit: www.vax121.com About […]
  • Posted by Elliot Willcox
  • On 20 May 2015
  • 0 Comments
  • Read More

VAXEAL CREATES LARGE EU EBOLA CONSORTIUM

Vaxeal has created a large EU and African consortium for the development of a new generation of pan-ebola vaccines Vevey, January 4, 2015: Vaxeal has created a large EU and African consortium comprising 14 different private and public institutions for the development a new generation of vaccines that provide protection against all major Ebola strains […]
  • Posted by Elliot Willcox
  • On 4 January 2015
  • 0 Comments
  • Read More

VAXEAL CEO APPOINTED BOARD MEMBER OF VACCINES EUROPE

Vevey, 5 February, 2014 – Vaxeal Holding SA today announced that its CEO, Ahmed Bouzidi, has been appointed new board member of Vaccines Europe, the specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA). Ahmed Bouzidi is the first vaccine SME representative to join Vaccines Europe.« I am delighted to be involved […]
  • Posted by Elliot Willcox
  • On 5 February 2014
  • 0 Comments
  • Read More

VAXEAL RECEIVES GRANT FROM FRENCH NATIONAL RESEARCH AGENCY

Vaxeal Research receives a grant from the French National Research Agency 18 December, 2013Evry, 18 December, 2013 – The consortium involving Vaxeal research SAS, INSERM, the European Hospital Georges Pompidou, and the CEA today announced that it received a grant of 500K€ from the French National Research Agency (ANR) for the completion of the pre-clinical […]
  • Posted by Elliot Willcox
  • On 18 December 2013
  • 0 Comments
  • Read More